StreetInsider.com News Articles

Leerink Reiterates Market Perform Rating on Hims and Hers (HIMS)

Tue, 02 Jun 2026 08:19:59 -0400

Leerink analyst Michael Cherny reiterated a Market Perform rating and $25.00 price target on Hims and Hers (NYSE: HIMS).

The analyst comments "We are updating our HIMS estimates to reflect today's completion of the Eucalyptus acquisition and recent financing that is partially funding the transaction. There are no major changes other than a deal close one month earlier than expected. This should lead to revenue guidance upside, as the deal is not currently in the guidance. We think global expansion is prudent (builds on the ZAVA acquisition), and acquiring a platform to kick off the build makes sense. That said, the

Form 8-K Hims & Hers Health, Inc. For: May 29

Tue, 02 Jun 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260602/26586842.html

Form 8-K Hims & Hers Health, Inc. For: May 29

Tue, 02 Jun 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260602/26586842.html

Hims & Hers completes acquisition of Eucalyptus

Tue, 02 Jun 2026 05:00:44 -0400

Hims & Hers Health Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, expanding the telemedicine company's international presence across Australia, Canada, Germany, Japan and the United Kingdom, according to a company statement.

The acquisition follows earlier purchases of ZAVA and Livewell, establishing Hims & Hers operations across multiple international markets including the United States, United Kingdom, Australia and Canada, with additional presence in France, Germany, Ireland, Spain and Japan.

Eucalyptus has served more than 850,000 customers and operates across several international markets. Tim Doyle, former CEO of Eucalyptus, will serve as Senior Vice President of International at Hims & Hers following

Hims & Hers completes acquisition of Eucalyptus

Tue, 02 Jun 2026 05:00:44 -0400

Hims & Hers completes acquisition of Eucalyptus

Tue, 02 Jun 2026 05:00:44 -0400

Hims & Hers completes acquisition of Eucalyptus

Tue, 02 Jun 2026 05:00:44 -0400

HIMS & HERS completes Eucalyptus acquisition to expand in Canada

Tue, 02 Jun 2026 05:00:33 -0400

Hims & Hers Health Inc. announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, according to a company statement. The transaction represents the company's expansion efforts in the Canadian healthcare market.

The acquisition follows Hims & Hers' launch in Canada in 2025, when it became the first platform to offer generic semaglutide to eligible Canadians. The combined platform will provide weight management, sexual health, and hair loss treatments to Canadian consumers.

Eucalyptus operates Juniper, a weight management program that provides treatment paired with clinical support. The acquisition allows Hims & Hers to expand its service offerings in Canada,

HIMS & HERS completes Eucalyptus acquisition to expand in Canada

Tue, 02 Jun 2026 05:00:33 -0400

Eucalyptus operates Juniper, a weight management program that provides treatment paired with clinical support. The acquisition allows Hims & Hers to expand its service offerings in Canada,

Hims & Hers completes Eucalyptus acquisition to expand in Germany

Tue, 02 Jun 2026 05:00:31 -0400

Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of weight management platform Juniper, according to a company statement. The transaction expands Hims & Hers' operations in Germany's telehealth market.

Juniper launched in Germany in March 2023, offering weight management services in a market where approximately one in five adults lives with obesity, according to data from Germany's Robert Koch Institute referenced in the announcement. The platform focuses on connecting women to weight loss care through personalized treatment and clinical support.

"Germany has taken meaningful steps to recognize obesity as a chronic disease, but access to effective,

Hims & Hers completes Eucalyptus acquisition to expand in Germany

Tue, 02 Jun 2026 05:00:31 -0400

"Germany has taken meaningful steps to recognize obesity as a chronic disease, but access to effective,

Hims & Hers completes Eucalyptus acquisition, enters Australia market

Tue, 02 Jun 2026 05:00:20 -0400

Hims & Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, the parent company of Australian healthcare brands Juniper, Pilot, Kin, and Software, according to a company statement. The transaction marks the telehealth company's entry into the Australian market.

Eucalyptus has served over 550,000 Australians since 2019 through its portfolio of digital health brands, which address conditions including weight management, reproductive care, and men's sexual health. The acquisition brings Eucalyptus's existing customer base under the Hims & Hers platform.

"Australians are among the most health-conscious consumers in the world, and Eucalyptus has already begun redefining what healthcare access can look

Hims & Hers completes Eucalyptus acquisition, enters Australia market

Tue, 02 Jun 2026 05:00:20 -0400

"Australians are among the most health-conscious consumers in the world, and Eucalyptus has already begun redefining what healthcare access can look

HIMS & Hers completes acquisition of Eucalyptus to enter Japan market

Tue, 02 Jun 2026 05:00:18 -0400

Hims & Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, the parent company of Juniper, marking the telehealth company's entry into the Japanese market.

The acquisition brings Hims & Hers' technology and clinical infrastructure to support Juniper's weight management services in Japan. Juniper launched in Japan in November 2023 and has established a customer base offering weight loss care in a market where people wait an average of six years to seek support for weight management, according to the company.

"In Japan, the need for accessible, quality weight management care has long outpaced what's available. Juniper has already started

HIMS & Hers completes acquisition of Eucalyptus to enter Japan market

Tue, 02 Jun 2026 05:00:18 -0400

Hims & Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, the parent company of Juniper, marking the telehealth company's entry into the Japanese market.

"In Japan, the need for accessible, quality weight management care has long outpaced what's available. Juniper has already started

Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

Tue, 02 Jun 2026 05:00:00 -0400

Closing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan

TOKYO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company's global growth and its formal entry into Japan. This milestone puts the full weight of Hims & Hers’ technology, data, and clinical infrastructure behind a platform that supports weight management care for people in Japan, a market the company approaches with deep respect for its distinct healthcare values and the trust people place in those who serve them.

Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

Tue, 02 Jun 2026 05:00:00 -0400

Closing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan

Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

Tue, 02 Jun 2026 05:00:00 -0400

Closing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan

Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

Tue, 02 Jun 2026 05:00:00 -0400

Closing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan

Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany

Tue, 02 Jun 2026 05:00:00 -0400

Closing brings world-class technology and clinical infrastructure to a market where Juniper has helped patients achieve clinically meaningful weight loss

BERLIN--(BUSINESS WIRE)-- Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, advancing its position as the world's largest consumer health platform. In Germany, the closing strengthens Juniper’s comprehensive, clinically rigorous, weight management offering with the technology, data, and infrastructure of Hims & Hers behind it.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602926942/en/

Closing brings
</article>
<article>
<h1>Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany</h1>
<p>Tue, 02 Jun 2026 05:00:00 -0400</p>
<p class=

Closing brings world-class technology and clinical infrastructure to a market where Juniper has helped patients achieve clinically meaningful weight loss

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602926942/en/

Closing brings world-class technology and clinical infrastructure to a market where Juniper has helped patients achieve clinically meaningful weight loss

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602926942/en/

Closing brings world-class technology and clinical infrastructure to a market where Juniper has helped patients achieve clinically meaningful weight loss

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602926942/en/

Closing brings
</article>
<article>
<h1>Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform</h1>
<p>Tue, 02 Jun 2026 05:00:00 -0400</p>
<p class=

Entering Australia for the first time, Hims & Hers will combine scale, technology, and clinical expertise to make personalised, whole-body care more accessible to every Australian

SYDNEY--(BUSINESS WIRE)-- Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus – the parent company of Juniper, Pilot, Kin, and Software – advancing its position as the world's largest consumer health platform and marking its official entry into Australia. This milestone puts the full weight of Hims & Hers’ technology, data, and clinical infrastructure behind a platform that has already transformed how over half a million Australians have accessed

Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform

Tue, 02 Jun 2026 05:00:00 -0400

Entering Australia for the first time, Hims & Hers will combine scale, technology, and clinical expertise to make personalised, whole-body care more accessible to every Australian